• ARL4C, FLSs, and Macrophage Dynamics in RA

  2026-08-07

  This study integrates single-cell and bulk transcriptomic data with cellular and collagen-induced arthritis models to identify ARL4C as a regulator of aggressive rheumatoid arthritis fibroblast-like synoviocytes. Its findings connect ARL4C-dependent FLS proliferation and invasion with macrophage polarization, offering a mechanistic framework for studying synovial inflammation and potential FLS-directed interventions.

• CGP 55845 Hydrochloride: Precision Tools for GABAB Modulatio

  2026-08-07

  Explore how CGP 55845 hydrochloride, a potent GABAB receptor antagonist, transforms in vitro neurotransmission assays and synaptic transmission research. This article uniquely bridges glial regulation insights with advanced experimental strategies for cognitive neuroscience.

• CTP Solution Enables Precision RNA Synthesis for mRNA Therap

  2026-08-06

  CTP Solution (100 mM) is transforming mRNA synthesis workflows by delivering ultra-pure, RNase/DNase-free nucleotide supply—critical for reproducible, high-yield in vitro transcription. Its integration into localized p21 mRNA-LNP therapies for bladder cancer demonstrates how optimizing nucleotide selection enhances both experimental reliability and translational impact.

• RNA Pol II Inhibition Triggers Apoptosis via Active Signalin

  2026-08-06

  Harper et al. (2025) demonstrate that inhibition of RNA polymerase II induces cell death through an active, regulated apoptotic pathway, rather than passive loss of transcription products. This discovery redefines the mechanistic landscape of cell death in transcription-targeted research and has direct implications for apoptosis modeling and drug development.

• Oscillatory mTORC1 Activity Coordinates Cell Cycle and Autop

  2026-08-05

  Joshi et al. reveal that mTORC1 activity is not static but instead oscillates throughout the cell cycle, peaking during S/G2 and reaching its lowest in mitosis and G1. This dynamic regulation influences both mitotic entry and the cell’s autophagic response, offering new insights for cell cycle research and the design of synchronization or DNA repair assays.

• 5X Protein Loading Buffer (Reducing): Technical Use in SDS-P

  2026-08-05

  5X Protein Loading Buffer (Reducing) addresses the need for consistent protein denaturation and disulfide bond reduction during SDS-PAGE, ensuring that protein separation is based solely on molecular weight. It is essential for workflows requiring reducing conditions and is not suitable for protocols that must preserve native or non-reducing protein conformations.

• 2,7-Dichlorodihydrofluorescein Diacetate in Advanced ROS Ass

  2026-08-04

  2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) empowers researchers to quantify intracellular oxidative stress with precision across microscopy, flow cytometry, and plate-based platforms. Discover optimized workflows, troubleshooting strategies, and novel insights from plastid genome research that elevate your ROS assay reliability.

• Tetraethylammonium Chloride: Expanding the Toolkit for Potas

  2026-08-04

  Explore the advanced scientific rationale and utility of Tetraethylammonium chloride (TEAC) in dissecting potassium channel function and vascular physiology. This article reveals novel insights from reference literature and offers actionable guidance for designing more precise experiments.

• Azithromycin Workflows: Applied Protocols in Bacterial Resea

  2026-08-03

  Azithromycin, a potent macrolide antibiotic from APExBIO, enables advanced experimental designs for bacterial infection models and resistance screening. This article distills step-by-step workflows, critical protocol parameters, and troubleshooting recommendations to maximize reproducibility and insight in bench research.

• SCH772984 (A3805): Reliable ERK1/2 Inhibition for Tumor Rese

  2026-08-03

  This article explores real-world experimental challenges when targeting the MAPK/ERK pathway and demonstrates how SCH772984 (SKU A3805) offers sensitive, selective, and reproducible ERK1/2 inhibition. Scenario-driven Q&A addresses cell assay optimization, data interpretation, and vendor selection, empowering researchers to enhance reliability in BRAF, NRAS, or KRAS mutant models.

• Prolonged Hypoxia Activates NLRP3 Inflammasome in Urothelial

  2026-08-02

  The reference study elucidates how extended enzyme-induced hypoxia, unlike brief hypoxic exposure, selectively activates the NLRP3 inflammasome in urothelial cells via a ROS/TXNIP pathway. These findings clarify the mechanistic basis of inflammation in bladder outlet obstruction and highlight practical considerations for in vitro modeling and potential interventions.

• Dlin-MC3-DMA Ionizable Cationic Liposome: mRNA & siRNA Deliv

  2026-08-01

  Dlin-MC3-DMA stands as the gold-standard ionizable cationic liposome for potent, safe, and tunable delivery of RNA therapeutics. This article unpacks machine learning-guided advances, hands-on protocol refinements, and troubleshooting strategies that maximize D-Lin-MC3-DMA performance for gene silencing and immunomodulation.

• Peroxidasin Drives GBM Progression via LDHA-Linked Glycolysi

  2026-07-31

  This study identifies peroxidasin (PXDN) as a crucial regulator of glycolytic metabolism and malignant behavior in glioblastoma, acting through modulation of lactate dehydrogenase A (LDHA). The findings suggest that PXDN may serve as a potential diagnostic marker and therapeutic target, providing mechanistic insight for metabolic intervention strategies in aggressive brain tumors.

• NMDA Receptor-Dependent Maturation of PV Interneuron Synapse

  2026-07-31

  This study reveals that NMDA receptor (NMDAR) function during early postnatal development is crucial for the maturation of GABAergic synaptic transmission from neocortical parvalbumin (PV) interneurons. Through genetic and pharmacological approaches, the authors show that impaired NMDAR signaling disrupts Cav2.1 channel recruitment and evoked GABA release, shedding light on mechanisms that may underlie altered excitatory/inhibitory balance relevant to schizophrenia.

• Micellar Spectrofluorimetric Estimation of Alfuzosin HCl in

  2026-07-30

  This study introduces a sensitive micellar spectrofluorimetric method for the simultaneous quantification of Alfuzosin HCl and vardenafil in dosage forms and human biological fluids. These advances support more precise pharmacokinetic and analytical workflows in benign prostatic hyperplasia (BPH) research.

457 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page